Relapsed/Refractory Cancers

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

Universal off-the-shelf CAR-T cells with dual-antigen targeting accelerate access by addressing tumor antigen variability.